OSRH logo
OSRH NASDAQ US

OSR Holdings, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Feb 2023
$0.55
▼ $-0.04 (-6.30%)
Vol 903K
3
Quality Score
fail
Mkt Cap
$14.5M
ROE
-15.8%
D/E
5.28
Beta
1.40
52W
$0–$13

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Sep 2025 $-0.12 $-0.10 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -16.8% -22.1% -16.8% -16.8% -16.8% -15.8%
P/E (TTM)
Net Margin 29.2%
Gross Margin 2.9%
D/E Ratio 5.06 6.22 5.06 5.06 5.06 5.28
Current Ratio 0.18 0.25 0.18 0.18 0.18 0.21

Key Ratios

ROA (TTM)
-8.5%
EPS (TTM)
$-1.73
52W High
$12.54
52W Low
$0.45
$0.45 52-Week Range $12.54

How does OSRH compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

OSRH AAPG ABEO ABOS ABP

OSRH valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

OSRH profitability vs Biotechnology peers

ROE
-15.8%
76% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-8.5%
82% above peers (-46.7%)
vs Peers
vs Industry
Top tier

OSRH financial health vs Biotechnology peers

D/E ratio
5.3
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.2
95% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.4
45% above peers (1.0)
vs Peers
vs Industry
More volatile

OSRH fundamentals radar

OSRH Peer median Industry

OSRH profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

OSRH vs peers: key metrics

Latest News

No related news yet